𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cell-Penetrating Mimics of Agonist-Activated G-Protein Coupled Receptors

✍ Scribed by Pernilla Östlund; Kalle Kilk; Maria Lindgren; Mattias Hällbrink; Yang Jiang; Metka Budihna; Katarina Cerne; Aljosa Bavec; Claes-Göran Östenson; Matjaz Zorko; Ülo Langel

Publisher
Springer Netherlands
Year
2005
Tongue
English
Weight
360 KB
Volume
11
Category
Article
ISSN
1573-3149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure–activity relationships of inve
Structure–activity relationships of inverse agonists for G-protein-coupled receptors
✍ Willem Soudijn; Ineke van Wijngaarden; Adriaan P. Ijzerman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract It has been recently established that G‐protein‐coupled receptors (GPCRs) can be constitutively active, i.e., they can be active in the absence of an agonist. This activity can be inhibited by so‐called inverse agonists. For a number of GPCRs, such inverse agonists have been developed a

Agonist-selective signaling of G protein
Agonist-selective signaling of G protein-coupled receptor: Mechanisms and implications
✍ Hui Zheng; Horace H. Loh; Ping-Yee Law 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract Agonist‐selective signaling or ligand‐biased signaling of G protein‐coupled receptor (GPCR) has become the focus of an increasing number of laboratories. The principle of this concept is that agonist possesses different abilities to activate different signaling pathways. Current review

A model of non-exclusive binding of agon
A model of non-exclusive binding of agonist and antagonist on g-protein coupled receptors
✍ Jaak Järv 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 330 KB

A modified concept of functioning of G-protein coupled receptors is presented, on the assumption that agonistic and antagonistic effects of drugs are related to their interaction with two separate receptor sites that exist simultaneously on a single receptor molecule and possess different ligand-spe